Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 17,197Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10ASTRAZENECA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 9562017

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 213756

Patent Use Code : U-2800

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-12

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 9562017

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 213756

Patent Use Code : U-2800

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-12

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 9156795

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-12

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 11813246

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-26

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 11813246

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-26

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 8178693

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-13

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 7425637

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-13

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 9156795

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-12

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 8178693

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-13

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELUMETINIB SULFATE

US Patent Number : 7425637

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 213756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-13

blank